Mostrar el registro sencillo del ítem

dc.contributor.authorPrieto García, Laura
dc.contributor.authorVicente Vicente, Rosa Laura 
dc.contributor.authorBlanco-Gozalo, Víctor
dc.contributor.authorHidalgo-Thomas, Omar
dc.contributor.authorGarcía Macias, María del Carmen
dc.contributor.authorKurtz, Armin
dc.contributor.authorLayton, Anita T
dc.contributor.authorSanz, Ana B
dc.contributor.authorMorales Martín, Ana Isabel 
dc.contributor.authorMartínez Salgado, José Carlos 
dc.contributor.authorPericacho Bustos, Miguel 
dc.contributor.authorSancho Martínez, Sandra María 
dc.contributor.authorLópez Hernández, Francisco José 
dc.date.accessioned2025-11-24T12:42:33Z
dc.date.available2025-11-24T12:42:33Z
dc.date.issued2020-07-27
dc.identifier.citationPrieto-García, L., Vicente-Vicente, L., Blanco-Gozalo, V., Hidalgo-Thomas, O., García-Macías, M. C., Kurtz, A., ... & López-Hernández, F. J. (2020). Pathophysiological mechanisms underlying a rat model of triple whammy acute kidney injury. Laboratory Investigation, 100(11), 1455-1464.es_ES
dc.identifier.urihttp://hdl.handle.net/10366/167989
dc.description.abstract[EN]Simultaneous administration of certain antihypertensive (renin-angiotensin system inhibitors and diuretics) and nonsteroidal anti-inflammatory drugs (NSAIDs) is associated with a renal toxicity syndrome known as "triple whammy" acute kidney injury (TW-AKI), yet poorly characterized at the pathophysiological level, as no specific experimental model exists on which to conduct preclinical research. Herein, we generated and characterized a rat model of TW-AKI (0.7 mg/kg/day trandolapril +400 mg/kg/day ibuprofen +20 mg/kg/day furosemide). Double treatments involving the NSAID caused a subclinical acute kidney injury, as they reduced glomerular filtration rate to a significant but not sufficient extent to increase Crpl concentration. Only the triple treatment generated an overt AKI with increased Crpl provided that animals were under partial water ingestion restriction. Histological examination revealed no evidence of tissue renal injury, and no proteinuria or makers of renal damage were detected in the urine. These findings, along with a normal fractional excretion of sodium and glucose, indicated that these drug combinations produce a prerenal type of AKI. In fact, blood pressure and renal blood flow were also reduced (most markedly following the triple combination), although renal dysfunction was more pronounced than expected for the corresponding pressure drop, supporting a key pathological role of the interference with renal autoregulation mechanisms. In summary, prerenal TW-AKI only occurs when volemia is challenged (i.e., by furosemide in partially water-deprived animals) under the effects of renin-angiotensin system inhibitors and NSAIDs. This model will facilitate further pathophysiological knowledge for a better diagnosis and clinical handling of this syndrome.es_ES
dc.description.sponsorshipInstituto de Salud Carlos III Ministerio de Economía y Competitividades_ES
dc.language.isoenges_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectacute kidney injuryes_ES
dc.subjecttriple whammyes_ES
dc.subjectprerenales_ES
dc.subjectdiagnosises_ES
dc.subjectpreclinicales_ES
dc.subject.meshIndoles *
dc.subject.meshIbuprofen *
dc.subject.meshAcute Kidney Injury *
dc.subject.meshRats *
dc.subject.meshAnimals *
dc.subject.meshAngiotensin-Converting Enzyme Inhibitors *
dc.subject.meshFurosemide *
dc.subject.meshDrug Therapy *
dc.subject.meshDiuretics *
dc.subject.meshAnti-Inflammatory Agents *
dc.subject.meshBlood Pressure *
dc.subject.meshRenal Circulation *
dc.titlePathophysiological mechanisms underlying a rat model of triple whammy acute kidney injuryes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publishversionhttps://doi.org/10.1038/s41374-020-0473-9es_ES
dc.identifier.doi10.1038/s41374-020-0473-9
dc.relation.projectIDPI14/01776es_ES
dc.relation.projectIDDTS15S/00166es_ES
dc.relation.projectIDPI15/01055es_ES
dc.relation.projectIDPI18/00996es_ES
dc.relation.projectIDPI19/00588es_ES
dc.relation.projectIDRD016/0009/0025es_ES
dc.relation.projectIDIPT-2012-0779-010000es_ES
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES
dc.audience.educationLevel
dc.identifier.pmid32719543
dc.identifier.essn1530-0307
dc.journal.titleLaboratory investigationes_ES
dc.volume.number100es_ES
dc.issue.number11es_ES
dc.page.initial1455es_ES
dc.page.final1464es_ES
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones_ES
dc.subject.decspresión sanguínea *
dc.subject.decsdiuréticos *
dc.subject.decsindoles *
dc.subject.decsanimales *
dc.subject.decsibuprofeno *
dc.subject.decslesión renal aguda *
dc.subject.decsratas *
dc.subject.decsfurosemida *
dc.subject.decscirculación renal *
dc.subject.decsinhibidores de la enzima covertidora de angiotensina *
dc.subject.decsantiinflamatorios *
dc.subject.decsfarmacoterapia *


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 Internacional